26% increase in SP for CPH on OTC is a great start for them - now compare that to IHL which has excellent management (no Blumenthals here), looking to list on the NASDAQ (where the big boys play) and with a lot more ammunition than this other crowd - we'll be a lot closer to getting FDA approval for any number of our drugs than CPH will, I can almost guarantee it.
IHL has also developed its own psychedelics arm and not gone out and bought one ( CPH has gone out and acquired minnow psychedelics outfit Halucenex - they really need to do something about that name)
Fingers crossed we soon get an update on the proposed listing!
DYOR and GLTAH.....
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-6173
-
-
- There are more pages in this discussion • 13,805 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)